Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1982 Oct;22(4):709–710. doi: 10.1128/aac.22.4.709

Concentrations of cefoxitin in gallbladder bile of cholecystectomy patients.

J F Hansbrough, J E Clark
PMCID: PMC183822  PMID: 7181483

Abstract

Cefoxitin was administered in a dose of 2 g intravenously to 17 patients scheduled for cholecystectomy. The concentrations of this agent in serum and gallbladder bile were measured simultaneously upon opening of the abdominal cavity. Concentrations of cefoxitin in excess of 10 microgram/ml were present in the gallbladder bile of 12 of the 13 patients from samples obtained between 35 and 165 min after cefoxitin infusion. Cystic or common duct obstruction did not preclude entry of the drug into gallbladder bile.

Full text

PDF
709

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brumfitt W., Kosmidis J., Hamilton-Miller J. M., Gilchrist J. N. Cefoxitin and cephalothin: antimicrobial activity, human pharmacokinetics, and toxicology. Antimicrob Agents Chemother. 1974 Sep;6(3):290–299. doi: 10.1128/aac.6.3.290. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Chetlin S. H., Elliott D. W. Preoperative antibiotics in biliary surgery. Arch Surg. 1973 Aug;107(2):319–323. doi: 10.1001/archsurg.1973.01350200179037. [DOI] [PubMed] [Google Scholar]
  3. Herlitz V., Langmaack H., Metzger M., Daschner F. D. Serum and tissue levels of cefoxitin in perioperative prophylaxis. J Antimicrob Chemother. 1980 Nov;6(6):717–722. doi: 10.1093/jac/6.6.717. [DOI] [PubMed] [Google Scholar]
  4. Levi J. U., Livingstone A. S., Martinez O. V., Zeppa R., Malinin T., Hutson D. G., Einhorn N. C. Biliary concentrations of cefamandole and its use in biliary tract surgery. Scand J Infect Dis Suppl. 1980;Suppl 25:55–57. [PubMed] [Google Scholar]
  5. Logan M. N., Wise R., Grimley R. P. Biliary levels of cefoxitin. J Antimicrob Chemother. 1979 Sep;5(5):620–621. doi: 10.1093/jac/5.5.620. [DOI] [PubMed] [Google Scholar]
  6. Moellering R. C., Jr, Dray M., Kunz L. J. Susceptibility of clinical isolates of bacteria to cefoxitin and cephalothin. Antimicrob Agents Chemother. 1974 Sep;6(3):320–323. doi: 10.1128/aac.6.3.320. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Mortimer P. R., Mackie D. B., Haynes S. Ampicillin levels in human bile in the presence of biliary tract disease. Br Med J. 1969 Jul 12;3(5662):88–89. doi: 10.1136/bmj.3.5662.88. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Neu H. C. Cefoxitin, a semisynthetic cephamycin antibiotic: antibacterial spectrum and resistance to hydrolysis by gram-negative beta-lactamases. Antimicrob Agents Chemother. 1974 Aug;6(2):170–176. doi: 10.1128/aac.6.2.170. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Nielsen M. L., Justesen T. Anaerobic and aerobic bacteriological studies in biliary tract disease. Scand J Gastroenterol. 1976;11(5):437–446. [PubMed] [Google Scholar]
  10. Polk H. C., Jr Better definition of indications for antibiotic prophylaxis in biliary tract operations. Surgery. 1977 Apr;81(4):478–479. [PubMed] [Google Scholar]
  11. Schrogie J. J., Rogers J. D., Yeh K. C., Davies R. O., Holmes G. I., Skeggs H., Martin C. M. Pharmacokinetics and comparative pharmacology of cefoxitin and cephalosporins. Rev Infect Dis. 1979 Jan-Feb;1(1):90–98. doi: 10.1093/clinids/1.1.90. [DOI] [PubMed] [Google Scholar]
  12. Shah P. M., Zwischenbrugger H., Stille W. In-vitro-Aktivität von Cefoxitin, einem neuen Cephalosporin. MMW Munch Med Wochenschr. 1976 Nov 5;118(45):1469–1472. [PubMed] [Google Scholar]
  13. Stapley E. O., Birnbaum J., Miller A. K., Wallick H., Hendlin D., Woodruff H. B. Cefoxitin and cephamycins: microbiological studies. Rev Infect Dis. 1979 Jan-Feb;1(1):73–89. doi: 10.1093/clinids/1.1.73. [DOI] [PubMed] [Google Scholar]
  14. Strachan C. J., Black J., Powis S. J., Waterworth T. A., Wise R., Wilkinson A. R., Burdon D. W., Severn M., Mitra B., Norcott H. Prophylactic use of cephazolin against wound sepsis after cholecystectomy. Br Med J. 1977 May 14;1(6071):1254–1256. doi: 10.1136/bmj.1.6071.1254. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Sutter V. L., Finegold S. M. Susceptibility of Anaerobic bacteria to carbenicillin, cefoxitin, and related drugs. J Infect Dis. 1975 Apr;131(4):417–422. doi: 10.1093/infdis/131.4.417. [DOI] [PubMed] [Google Scholar]
  16. Sutter V. L., Kirby B., Finegold S. M. In vitro activity of cefoxitin and parenterally administered cephalosporins against anaerobic bacteria. Rev Infect Dis. 1979 Jan-Feb;1(1):218–223. doi: 10.1093/clinids/1.1.218. [DOI] [PubMed] [Google Scholar]
  17. Trachtenberg L., Fagelman K. M., Polk H. C., Jr The biliary tract kinetics of some cephalosporin antibiotics. Surgery. 1978 Sep;84(3):342–347. [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES